MedPath

The Potential Role of Hydrocortisone in Acute Phosphide Poisoning: A Randamized Clinical Trial

Phase 2
Conditions
Injury, Occupational Diseases, Poisoning
Registration Number
PACTR201811766698931
Lead Sponsor
Tanta University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Adult patients with severe acute phosphide poisoning manifested by
systolic blood pressure (SBP) =80 mmHg
pH =7.2, or HCO3 =15 meq/L

Exclusion Criteria

•Asymptomatic patients.
•Patients ingested or exposed to other substances in addition to phosphide.
•Patients with major medical conditions (e.g. cardiovascular disease, renal or hepatic failure).
•Patients on steroids therapy.
•Patients with medical interference by corticosteroid 24 hours before admission.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath